Annual Review of Cancer Biology

Papers
(The H4-Index of Annual Review of Cancer Biology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology93
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer63
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond33
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance31
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo31
Targeting Solid Tumors with Bispecific T Cell Engager Immune Therapy30
Mitochondria, OXPHOS, and Cancer Progression: A Modular View28
Lessons from 3D Reconstruction of Cancer28
Natural and Engineered Cytokines as Cancer Therapeutics27
Allogeneic CAR T Cell Therapy for Cancer26
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity26
Cancer Genomic Rearrangements and Copy Number Alterations from Errors in Cell Division25
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology23
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?22
Caught in a Web: Emerging Roles of Neutrophil Extracellular Traps in Cancer20
Road Map to Defeat Pancreatic Cancer19
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies19
Cancer Dependency Map: Past and Present17
0.013140916824341